Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
15
GBIO Quote, Financials, Valuation and Earnings
Last price:
$1.16
Seasonality move
:
5.59%
Day range:
$1.06 - $1.21
52-week range:
$0.75 - $4.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.26x
P/B ratio:
0.76x
Volume:
884.7K
Avg. volume:
342.1K
1-year change:
-30%
Market cap:
$79.5M
Revenue:
$5.9M
EPS (TTM):
-$2.19
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $5.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $50.1M | $58.5M | $85.2M | $96.7M | $93.6M | |
| Selling, General & Admin | $12.2M | $22.6M | $33.9M | $44.5M | $50.9M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $62.3M | $81.1M | $119.1M | $141.2M | $144.5M | |
| Operating Income | -$62.3M | -$81.1M | -$119.1M | -$141.2M | -$138.6M | |
| Net Interest Expenses | -- | -- | $50K | -- | -- | |
| EBT. Incl. Unusual Items | -$61.3M | -$80.5M | -$119.2M | -$136.6M | -$126.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$61.3M | -$80.5M | -$119.2M | -$136.6M | -$126.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$61.3M | -$80.5M | -$119.2M | -$136.6M | -$126.6M | |
| Basic EPS (Cont. Ops) | -$1.95 | -$2.95 | -$2.12 | -$2.35 | -$1.96 | |
| Diluted EPS (Cont. Ops) | -$1.95 | -$2.95 | -$2.12 | -$2.35 | -$1.96 | |
| Weighted Average Basic Share | $31.4M | $27.3M | $56.3M | $58.1M | $64.5M | |
| Weighted Average Diluted Share | $31.4M | $27.3M | $56.3M | $58.1M | $64.5M | |
| EBITDA | -$60.4M | -$77.7M | -$114.6M | -$136.1M | -$133.3M | |
| EBIT | -$62.3M | -$81.1M | -$119.1M | -$141.2M | -$138.6M | |
| Revenue (Reported) | -- | -- | -- | -- | $5.9M | |
| Operating Income (Reported) | -$62.3M | -$81.1M | -$119.1M | -$141.2M | -$138.6M | |
| Operating Income (Adjusted) | -$62.3M | -$81.1M | -$119.1M | -$141.2M | -$138.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $2.1M | $7.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | 252% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $15.3M | $22M | $21.2M | $21.9M | $15.1M | |
| Selling, General & Admin | $5.7M | $9.7M | $11.5M | $11.6M | $9.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$1.2M | |
| Operating Expenses | $21M | $31.7M | $32.7M | $33.5M | $24.3M | |
| Operating Income | -$21M | -$31.7M | -$32.7M | -$31.4M | -$16.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$20.8M | -$31.9M | -$31.3M | -$28.3M | -$15.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$20.8M | -$31.9M | -$31.3M | -$28.3M | -$15.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$20.8M | -$31.9M | -$31.3M | -$28.3M | -$15.3M | |
| Basic EPS (Cont. Ops) | -$0.46 | -$0.56 | -$0.53 | -$0.43 | -$0.23 | |
| Diluted EPS (Cont. Ops) | -$0.46 | -$0.56 | -$0.53 | -$0.43 | -$0.23 | |
| Weighted Average Basic Share | $45.5M | $56.6M | $58.9M | $65.9M | $66.7M | |
| Weighted Average Diluted Share | $45.5M | $56.6M | $58.9M | $65.9M | $66.7M | |
| EBITDA | -$20M | -$30.5M | -$31.3M | -$30.1M | -$15.5M | |
| EBIT | -$21M | -$31.7M | -$32.7M | -$31.4M | -$16.7M | |
| Revenue (Reported) | -- | -- | -- | $2.1M | $7.6M | |
| Operating Income (Reported) | -$21M | -$31.7M | -$32.7M | -$31.4M | -$16.7M | |
| Operating Income (Adjusted) | -$21M | -$31.7M | -$32.7M | -$31.4M | -$16.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $18.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $54.9M | $79.8M | $97M | $87.3M | $73.7M | |
| Selling, General & Admin | $18M | $32.7M | $40.5M | $50.6M | $42.5M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$59.6M | |
| Operating Expenses | $72.9M | $112.5M | $137.4M | $137.9M | $116.2M | |
| Operating Income | -$72.9M | -$112.5M | -$137.4M | -$134.8M | -$97.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$72.4M | -$112.4M | -$135.2M | -$123.8M | -$145.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$72.4M | -$112.4M | -$135.2M | -$123.8M | -$145.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$72.4M | -$112.4M | -$135.2M | -$123.8M | -$145.5M | |
| Basic EPS (Cont. Ops) | -$2.90 | -$2.10 | -$2.34 | -$1.98 | -$2.19 | |
| Diluted EPS (Cont. Ops) | -$2.90 | -$2.10 | -$2.34 | -$1.98 | -$2.19 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$69.8M | -$108.1M | -$132.5M | -$129.5M | -$92.6M | |
| EBIT | -$72.9M | -$112.5M | -$137.4M | -$134.8M | -$97.7M | |
| Revenue (Reported) | -- | -- | -- | -- | $18.6M | |
| Operating Income (Reported) | -$72.9M | -$112.5M | -$137.4M | -$134.8M | -$97.7M | |
| Operating Income (Adjusted) | -$72.9M | -$112.5M | -$137.4M | -$134.8M | -$97.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $3M | $15.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $42.2M | $63.4M | $75.1M | $65.7M | $45.8M | |
| Selling, General & Admin | $14.6M | $24.8M | $31.4M | $37.5M | $29.1M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -$59.6M | |
| Operating Expenses | $56.8M | $88.2M | $106.5M | $103.2M | $74.9M | |
| Operating Income | -$56.8M | -$88.2M | -$106.5M | -$100.1M | -$59.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$56.3M | -$88.2M | -$104.2M | -$91.4M | -$110.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$56.3M | -$88.2M | -$104.2M | -$91.4M | -$110.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$56.3M | -$88.2M | -$104.2M | -$91.4M | -$110.3M | |
| Basic EPS (Cont. Ops) | -$2.39 | -$1.57 | -$1.80 | -$1.43 | -$1.66 | |
| Diluted EPS (Cont. Ops) | -$2.39 | -$1.57 | -$1.80 | -$1.43 | -$1.66 | |
| Weighted Average Basic Share | $98.8M | $168.3M | $173M | $191.8M | $199.7M | |
| Weighted Average Diluted Share | $98.8M | $168.3M | $173M | $191.8M | $199.7M | |
| EBITDA | -$54.3M | -$84.8M | -$102.7M | -$96.2M | -$55.5M | |
| EBIT | -$56.8M | -$88.2M | -$106.5M | -$100.1M | -$59.2M | |
| Revenue (Reported) | -- | -- | -- | $3M | $15.7M | |
| Operating Income (Reported) | -$56.8M | -$88.2M | -$106.5M | -$100.1M | -$59.2M | |
| Operating Income (Adjusted) | -$56.8M | -$88.2M | -$106.5M | -$100.1M | -$59.2M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15.1M | $62.9M | $375.1M | $93.2M | $66.4M | |
| Short Term Investments | -- | $199.4M | -- | $185.9M | $197.9M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $2.6M | $5.4M | -- | $7M | $3.8M | |
| Other Current Assets | -- | -- | $4M | $259K | $290K | |
| Total Current Assets | $18.2M | $267.7M | $379.2M | $287M | $272.6M | |
| Property Plant And Equipment | $21.8M | $23.8M | $91M | $81.4M | $95.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.1M | $2.3M | $6.1M | $7.4M | $6.1M | |
| Total Assets | $42.1M | $294.2M | $476.8M | $376.3M | $374.8M | |
| Accounts Payable | $2.3M | $267K | $2M | $662K | $2.3M | |
| Accrued Expenses | $6.9M | $3M | $3.9M | $3M | $2.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $4.6M | $7.1M | $8.1M | |
| Other Current Liabilities | -- | $444K | $676K | $426K | $406K | |
| Total Current Liabilities | $9.2M | $11.2M | $18.8M | $19.2M | $39.9M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $140.7M | $26.1M | $95M | $93.8M | $171.6M | |
| Common Stock | $1K | $5K | $6K | $6K | $7K | |
| Other Common Equity Adj | -- | $9K | -- | -$83K | $274K | |
| Common Equity | -$98.6M | $268M | $381.7M | $282.5M | $203.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$98.6M | $268M | $381.7M | $282.5M | $203.1M | |
| Total Liabilities and Equity | $42.1M | $294.2M | $476.8M | $376.3M | $374.8M | |
| Cash and Short Terms | $15.1M | $262.3M | $375.1M | $279.1M | $264.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $58.6M | $388.3M | $134.5M | $93.4M | $21.7M | |
| Short Term Investments | $221.8M | $10M | $166.7M | $197.7M | $163.1M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $5.4M | $4.9M | $9M | -- | -- | |
| Other Current Assets | -- | -- | -- | $6.1M | $4.3M | |
| Total Current Assets | $285.8M | $403.3M | $310.6M | $297.8M | $191.3M | |
| Property Plant And Equipment | $22.9M | $54.2M | $84.6M | $76.8M | $37.2M | |
| Long-Term Investments | -- | -- | -- | -- | $15M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.2M | $6.1M | $7.2M | $6.5M | $5.3M | |
| Total Assets | $310.9M | $464M | $402.8M | $381.5M | $248.8M | |
| Accounts Payable | $418K | $520K | $1.7M | $2.7M | $1.7M | |
| Accrued Expenses | $2.9M | $3.7M | $2.2M | $3.3M | $1.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $4.4M | $6.6M | $8.7M | $10.8M | |
| Other Current Liabilities | $640K | $740K | $370K | $370K | $405K | |
| Total Current Liabilities | $9.2M | $14.5M | $17.3M | $32.8M | $30.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $24.4M | $56.8M | $94.1M | $149.6M | $144.3M | |
| Common Stock | $5K | $6K | $6K | $7K | $7K | |
| Other Common Equity Adj | $26K | -- | -$302K | -$4K | $319K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $286.5M | $407.2M | $308.7M | $231.9M | $104.4M | |
| Total Liabilities and Equity | $310.9M | $464M | $402.8M | $381.5M | $248.8M | |
| Cash and Short Terms | $280.4M | $398.4M | $301.2M | $291M | $184.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$61.3M | -$80.5M | -$119.2M | -$136.6M | -$126.6M | |
| Depreciation & Amoritzation | $1.9M | $3.4M | $4.5M | $5.1M | $5.3M | |
| Stock-Based Compensation | $4.2M | $8.4M | $17.9M | $24.5M | $24.3M | |
| Change in Accounts Receivable | $840K | $448K | -- | -$395K | -$3.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$40.3M | -$70.1M | -$91.8M | -$102.4M | -$52.7M | |
| Capital Expenditures | $20M | $5.5M | $6M | $8.8M | $7.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $48M | -$205.2M | $193M | -$192.5M | -$9.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$22K | -$3.2M | -$955K | -$631K | -$729K | |
| Cash From Financing | $78K | $323.1M | $214.7M | $13M | $35.8M | |
| Beginning Cash (CF) | $9.5M | $17.2M | $64.9M | $380.8M | $98.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.7M | $47.8M | $315.9M | -$282M | -$26.6M | |
| Ending Cash (CF) | $17.2M | $64.9M | $380.8M | $98.9M | $72.2M | |
| Levered Free Cash Flow | -$60.3M | -$75.7M | -$97.8M | -$111.2M | -$60.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$20.8M | -$31.9M | -$31.3M | -$28.3M | -$15.3M | |
| Depreciation & Amoritzation | $939K | $1.2M | $1.4M | $1.3M | $1.2M | |
| Stock-Based Compensation | $2.2M | $5M | $5.8M | $6M | $3.8M | |
| Change in Accounts Receivable | -- | -- | $1.4M | -$320K | -$875K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$18.5M | -$22.6M | -$20.5M | -$24.9M | -$19.5M | |
| Capital Expenditures | -- | -- | -- | $610K | $91K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$93.9M | $22.2M | -$12.6M | -$26.6M | $12.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.7M | -$392K | -$394K | -$131K | -$16K | |
| Cash From Financing | -$648K | $306K | $9.3M | -$131K | -$3K | |
| Beginning Cash (CF) | $173.7M | $394.1M | $164M | $150.7M | $30.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$113.1M | -$84K | -$23.8M | -$51.6M | -$6.8M | |
| Ending Cash (CF) | $60.7M | $394M | $140.2M | $99.1M | $23.8M | |
| Levered Free Cash Flow | -$20M | -$23.5M | -$21.1M | -$25.5M | -$19.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$72.4M | -$112.4M | -$135.2M | -$123.8M | -$145.5M | |
| Depreciation & Amoritzation | $3.1M | $4.4M | $4.9M | $5.3M | $5.1M | |
| Stock-Based Compensation | $6.1M | $16.2M | $23.6M | $24.1M | $17.5M | |
| Change in Accounts Receivable | $2.6M | -- | -$395K | -$265K | -$5.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$63.6M | -$89.4M | -$100.2M | -$50.8M | -$97.8M | |
| Capital Expenditures | -- | -- | -- | $2.1M | $6.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$220.6M | $206.2M | -$167M | -$26.2M | $22.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$983K | -$457K | -$814K | -$274K | |
| Cash From Financing | $320.9M | $216.5M | $13.3M | $35.8M | $183K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $36.7M | $333.4M | -$253.9M | -$41.1M | -$75.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$68.5M | -$94.3M | -$111.2M | -$54.3M | -$104.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$56.3M | -$88.2M | -$104.2M | -$91.4M | -$110.3M | |
| Depreciation & Amoritzation | $2.4M | $3.4M | $3.8M | $3.9M | $3.8M | |
| Stock-Based Compensation | $5M | $12.8M | $18.6M | $18.3M | $11.4M | |
| Change in Accounts Receivable | $448K | -- | -$395K | -$265K | -$2.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$51.8M | -$71M | -$79.4M | -$27.8M | -$72.8M | |
| Capital Expenditures | -- | -- | -- | $2.1M | $2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$225.5M | $185.9M | -$174.1M | -$7.8M | $24.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.2M | -$942K | -$444K | -$627K | -$172K | |
| Cash From Financing | $320.8M | $214.2M | $12.9M | $35.7M | $106K | |
| Beginning Cash (CF) | $297.5M | $827.4M | $887.5M | $350.9M | $142.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $43.5M | $329.1M | -$240.7M | $189K | -$48.4M | |
| Ending Cash (CF) | $340.9M | $1.2B | $646.8M | $351.1M | $94.3M | |
| Levered Free Cash Flow | -$55.5M | -$74.1M | -$87.6M | -$30.6M | -$74.8M | |
Get GBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GBIO
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
0.76x
1.84x
Price / LTM sales
4.26x
1.86x
Growth Metrics
GBIO
Sector
Revenue growth
252%
7.1%
Earnings growth
--
1.82%
Revenue (5-year growth)
177.31%
8.72%
Earnings forecast
-$0.28
-$0.20
Profitability
GBIO
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
-92.44%
-14.09%
Return on assets
-46.74%
-11.79%
Return on equity
-92.44%
-14.85%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
6
Estimated Next Earnings Date
Feb
5
Balance Sheet
GBIO
Sector
Total cash
$184.8M
$46.9M
Short term investments
$197.9M
$44M
Total assets
$374.8M
$142M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 0.73% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.55% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.65% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
